Dear Illumina Stock Fans, Mark Your Calendars for September 21 Illumina stock is joining the S&P 500 on Sept. 21. Here's why that matters, what's fueling growth, and what investors should watch next. Barchart · Sep 9
Scale AI taps former Google Cloud executive as CEO Scale AI appointed Francis DeSouza as chief executive officer, effective August 10. DeSouza brings over thirty years of enterprise technology experience to the AI company. He previously led Google Cloud's security products and served as Illumina's CEO. Scale AI recently added BP and Mayo Clinic as new enterprise customers. The… The Economic Times · Jul 30
US CEOs seek China business gains from Trump-Xi summit American business leaders are heading to China for a summit with President Xi Jinping. They aim to resolve ongoing business challenges and secure new opportunities. Companies like Mastercard, Visa, Tesla, and BlackRock are seeking regulatory approvals and market access. The visit is seen as a political opening to accelerate discussions… The Economic Times · May 12
Biotech ETFs Come Alive As Illumina Soars 23% — Is The Genomics Winter Finally Over? Biotech investors finally got a dose of good news this week. Illumina Inc (NASDAQ:ILMN) staged a powerful comeback, with the stock surging over 23% on Friday after topping its third-quarter guidance while narrowing its full-year revenue decline forecast. Now, the rally of this genomics firm has rippled through the ETF… Benzinga · Nov 3, 2025
DNA Sequencing Firm Illumina Sees Strong Clinical Market Momentum, Stock Soars Illumina Inc. (NASDAQ:ILMN) stock is trading higher after the company reported better-than-expected third-quarter earnings. Benzinga · Oct 31, 2025
JPMorgan, Alibaba, Columbia Banking System And A Health Care Stock On CNBC's 'Final Trades' On CNBC's “Halftime Report Final Trades,” on Monday, Joshua Brown, co-founder and CEO of Ritholtz Wealth Management, said JPMorgan Chase Co. (NYSE:JPM) is still his favorite financial as a long-term investor. The stock looks great, he added. Benzinga · Oct 21, 2025
Illumina Settles With DOJ, Veterans To End Whistleblower Lawsuit Illumina Inc. (NASDAQ:ILMN) has agreed to pay $9.8 million to resolve allegations it knowingly sold genomic sequencing systems with cybersecurity vulnerabilities to several U.S. government agencies. Benzinga · Aug 6, 2025
Cathie Wood's Ark Invest Loads Up On Coinbase, Roku, Illumina, And Bitmine Immersion On Friday, Cathie Wood-led Ark Invest made significant trades involving a number of prominent stocks including Coinbase Global Inc. (NASDAQ:COIN), Roku Inc. (NASDAQ:ROKU), Illumina Inc. (NASDAQ:ILMN), and Bitmine Immersion Technologies Inc. (NASDAQ:BMNR). Benzinga · Aug 2, 2025
These Analysts Boost Their Forecasts On Illumina Following Upbeat Results Illumina, Inc. (NASDAQ:ILMN) reported better-than-expected earnings for the second quarter on Thursday. Benzinga · Aug 1, 2025
Why Cathie Wood Is Loading Up on This Hot Growth Stock (And Should You?) This dip in Illumina’s stock could be an attractive opportunity for long-term growth investors. Barchart · Jul 25, 2025
China Announces Tariffs On American Imports In Retaliation China retaliates against US tariffs with its own tariffs and export controls, including an anti-monopoly probe on Google. Top News · Feb 4, 2025
Pharma giant Regeneron is spending $119.5M on the world’s largest, most diverse genetic database using DNA from patient volunteers The Fortune 500 pharma giant will sequence the exomes of 10 million people, with the goal of developing new therapies and more. Fortune · Jan 16, 2025
Experts warn DNA sequencers are vulnerable to bootkit attacks The iSeq 100 device did not come with standard boot protections, allowing crooks to establish persistence. TechRadar · Jan 9, 2025
Dr. Oz turbocharges Medicare Advantage and everyone monitors their glucose: 10 health care predictions for 2025 from top investors Although Trump is entering the White House with an electoral mandate, he will not spend any political capital on health care legislation. Fortune · Dec 6, 2024
Barchart · Jul 29, 2024 What You Need to Know Ahead of Illumina's Earnings Release Illumina is expected to release its second-quarter earnings next month, analysts expect a double-digit earnings dip.
StockNews.com · Jul 15, 2024 3 Biopharma Stocks to Buy for Long-Term Growth With the rising investment in personalized medicine research and development and growing clinical trials, the biopharma industry’s prospects appear promising. Hence, quality biotech stocks, Alnylam Pharmaceuticals (ALNY), Illumina (ILMN), and Gilead Sciences (GILD) with long-term growth might be solid buys. Read more….
StockNews.com · May 14, 2024 3 Biotech Stocks to Monitor for May Moves The biotech industry is well poised to flourish, buoyed by its strong emphasis on technology-driven advancements to address complex medical challenges and government funding. Hence, quality biotech stocks Harmony Biosciences Holdings (HRMY), Illumina (ILMN), and Compugen (CGEN) could be ideal watchlist additions for May. Read more….
Top News · Apr 10, 2024 Illumina CFO Goswami To Depart, Dhingra To Succeed Illumina announces CFO transition as Mr. Goswami departs and Mr. Dhingra steps in to lead the company's financial management.
StockNews.com · Apr 9, 2024 3 Biotech Stocks to Buy in 2024 The biotech industry is expected to grow rapidly due to rising demand for tailored treatments, increased R&D spending, and technological advancements. Therefore, fundamentally strong biotech stocks Harmony Biosciences Holdings (HRMY), Illumina (ILMN), and Halozyme Therapeutics (HALO) could be worth adding to your portfolio. Read on.
Top News · Mar 21, 2024 Court Adviser Supports Curbing Powers Of GRAIL-Illumina Merger Legal battle between GRAIL-M-A-ILLUMINA-EU and Illumina over merger powers may reshape industry landscape and set new precedents.
Barchart · Mar 21, 2024 Stock Indexes Climb to Record Highs on Expectations for Fed Rate Cuts The S&P 500 Index ($SPX ) (SPY ) this morning is up +0.48%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.49%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.90%. Stocks this morning extended Wednesday’s rally, with the S&P 500, Dow Jones Industrials,...
StockNews.com · Mar 15, 2024 3 B-Rated Biotech Stocks to Boost Your Bottom Line The biotech industry’s growth prospects look promising due to innovative drugs and therapies, government initiatives, and technological advancements. Therefore, investors could consider buying fundamentally strong biotech stocks BioMarin Pharmaceutical (BMRN), Illumina (ILMN), and Harmony Biosciences (HRMY). These stocks are B-rated (Buy) in our proprietary rating system. Read on.
StockNews.com · Mar 15, 2024 3 Popular Biotech Stocks to Capitalize on Gains The biotech industry’s rapid expansion is driven by rising healthcare sending, groundbreaking innovations, and strategic collaborations, propelling the growth of biopharma companies. Thus, it could be wise to invest in popular biotech stocks Illumina (ILMN), Shionogi (SGIOY), and Regeneron Pharmaceuticals (REGN) for substantial gains. Keep reading….
StockNews.com · Feb 29, 2024 3 Biotech Stocks to Buy for Profits Beyond 2024 The biotech industry is expected to deliver steady returns amid rising medical needs and increased research and development investment. Therefore, fundamentally strong biotech stocks Illumina (ILMN), Innoviva (INVA) and Puma Biotechnology (PBYI) might be ideal additions to your portfolio. Read on.
StockNews.com · Feb 2, 2024 3 Biotech Stocks Investors Are Watching for Future Growth A wide range of applications across several sectors, supportive government initiatives, rapid technological advancements, and shifting market dynamics position the biotechnology industry for robust long-term growth. Given the industry’s bright outlook, biotech stocks MannKind (MNKD), Illumina (ILMN), and TG Therapeutics (TGTX) could be ideal watchlist additions for potential growth. Read…